InvestorsObserver
×
News Home

Is GW Pharmaceuticals PLC- ADR (GWPH) A Winner in the Healthcare Sector?

Tuesday, June 16, 2020 11:53 AM | InvestorsObserver Analysts

Mentioned in this article

Is GW Pharmaceuticals PLC- ADR (GWPH) A Winner in the Healthcare Sector?

GW Pharmaceuticals PLC- ADR (GWPH) is around the top of the Healthcare sector according to InvestorsObserver.

GWPH received an overall rating of 59, which means that it scores higher than 59% of stocks. Additionally, GW Pharmaceuticals PLC- ADR scored a 77 in the Healthcare sector, ranking it higher than 77% of stocks in that sector.

Overall Score - 59
GWPH has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on GWPH!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds.

The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With GW Pharmaceuticals PLC- ADR Stock Today?

GW Pharmaceuticals PLC- ADR (GWPH) stock is trading at $125.77 as of 11:50 AM on Tuesday, Jun 16, an increase of $3.50, or 2.86% from the previous closing price of $122.27. The stock has traded between $123.15 and $126.78 so far today. Volume today is light. So far 60,008 shares have traded compared to average volume of 386,189 shares.

To screen for more stocks like GWPH click here.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App